{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:47:13Z","timestamp":1791121633775,"version":"4.1.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/mcg.0b013e318230928b","type":"journal-article","created":{"date-parts":[[2011,10,12]],"date-time":"2011-10-12T04:29:39Z","timestamp":1318393779000},"page":"S168-S171","source":"Crossref","is-referenced-by-count":163,"title":["Recommendations for Probiotic Use\u20142011 Update"],"prefix":"10.1097","volume":"45","author":[{"given":"Martin H.","family":"Floch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Allan","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ellen","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George T.","family":"Macfarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J.","family":"Flint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levinus A.","family":"Dieleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Ringel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Guandalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran P.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210305","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00004836-200603000-00022","article-title":"Recommendations for probiotic use.","volume":"40","author":"Floch","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"R2-15-20210305","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1097\/MCG.0b013e31816b903f","article-title":"Recommendations for probiotic use-2008.","volume":"42","author":"Floch","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"R4-15-20210305","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1097\/MCG.0b013e3182274249","article-title":"Interactions between microbes and the gut epithelium.","volume":"45","author":"Madsen","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R5-15-20210305","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1097\/MCG.0b013e318227414a","article-title":"Impact of probiotics on colonizing microbiota of the gut.","volume":"45","author":"Sanders","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R6-15-20210305","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1097\/MCG.0b013e31822fecfe","article-title":"Fermentation in the Human Large Intestine; Its Physiologic Consequences, and the Potential Contribution of Prebiotics.","volume":"45","author":"Macfarlane","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R7-15-20210305","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1097\/MCG.0b013e31821f44c4","article-title":"Obesity and the microbiome.","volume":"45","author":"Flint","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R8-15-20210305","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1097\/MCG.0b013e31822103f7","article-title":"Probiotics in the treatment of human inflammatory bowel diseases: update 2011.","volume":"45","author":"Meijer","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R9-15-20210305","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1097\/MCG.0b013e31822d32d3","article-title":"The rationale and clinical effectiveness of probiotics in irritable bowel syndrome.","volume":"45","author":"Ringel","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R10-15-20210305","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1097\/MCG.0b013e3182257e98","article-title":"Probiotics for prevention and treatment of diarrhea.","volume":"45","author":"Guandalini","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R11-15-20210305","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1097\/MCG.0b013e31822ec787","article-title":"Probiotics in Clostridium difficile infection.","volume":"45","author":"Na","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R13-15-20210305","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1097\/MCG.0b013e318228b799","article-title":"Probiotics in the prevention of necrotizing enterocolitis.","volume":"45","author":"Ganguli","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R14-15-20210305","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1097\/MCG.0b013e318222e603","article-title":"Fecal microbiotic transplantation for recurrent Clostridium difficile infection.","volume":"45","author":"Brandt","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R15-15-20210305","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2036.2006.03202.x","article-title":"Meta-analysis. Saccharomyces boulardii for treating acute diarrhea in children.","volume":"25","author":"Szujewsku","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R16-15-20210305","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00005176-200001000-00018","article-title":"Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multi-center European Trial.","volume":"30","author":"Guandalini","year":"2000","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R17-15-20210305","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00005176-199704000-00008","article-title":"Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children.","volume":"24","author":"Shornikova","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R18-15-20210305","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1097\/MCG.0b013e3181674087","article-title":"Probiotics for children with diarrhea: an update.","volume":"42","author":"Guandalini","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"R19-15-20210305","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/MCG.0b013e3181646d09","article-title":"Role of probiotics in antibiotic associated diarrhea, Clostridium difficile associated diarrhea and recurrent Clostridium difficile diarrhea.","volume":"42","author":"Surawicz","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"R20-15-20210305","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/MCG.0b013e3181618ab7","article-title":"Probiotics for prevention of antibiotic-associated diarrhea.","volume":"42","author":"Doron","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"R21-15-20210305","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/bmj.39231.599815.55","article-title":"Use of probiotic Lactobacillus preparation to prevent diarrhea associated with antibiotics: randomized double blind placebo controlled trial.","volume":"355","author":"Hickson","year":"2007","journal-title":"BMJ"},{"key":"R22-15-20210305","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00004836-200603000-00017","article-title":"Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile diarrhea.","volume":"40","author":"Katz","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"R23-15-20210305","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1053\/gast.2000.9370","article-title":"Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.","volume":"119","author":"Gionchetti","year":"2000","journal-title":"Gastroenterology"},{"key":"R24-15-20210305","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0016-5085(03)00171-9","article-title":"Prophylactis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.","volume":"124","author":"Gionchetti","year":"2003","journal-title":"Gastroenterology"},{"key":"R25-15-20210305","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gut.53.1.108","article-title":"Once-daily high-dose probiotic therapy (VSL3) for maintaining remission in recurrent or refractory pouchitis.","volume":"53","author":"Mimura","year":"2004","journal-title":"Gut"},{"key":"R26-15-20210305","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s10350-007-9068-4","article-title":"High-dose probiotics for the treatment of active pouchitis.","volume":"50","author":"Gionchetti","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"R27-15-20210305","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(98)06343-0","article-title":"Nonpathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomized trial.","volume":"354","author":"Rembacken","year":"1999","journal-title":"Lancet"},{"key":"R28-15-20210305","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1572-0241.2005.41794.x","article-title":"VSL3 probiotic-mixture induces remission in patients with active ulcerative colitis.","volume":"100","author":"Bibiloni","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R29-15-20210305","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ajg.2008.118","article-title":"Effect of a probiotic preparation (VSL3) on induction and maintenance of remission in children with ulcerative colitis.","volume":"104","author":"Miele","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R30-15-20210305","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/gut.2003.037747","article-title":"Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.","volume":"53","author":"Kruis","year":"2004","journal-title":"Gut"},{"key":"R31-15-20210305","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00004836-199712000-00021","article-title":"Crohns disease and Escherichia coli: a new approach in therapy to maintain remission of colonic Crohns disease.","volume":"25","author":"Malchow","year":"1997","journal-title":"J Clin Gastroenterol"},{"key":"R32-15-20210305","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1023\/A:1005588911207","article-title":"Saccharomyces boulardii in maintenance treatment of Crohns disease.","volume":"45","author":"Guslandi","year":"2000","journal-title":"Dig Dis Sci"},{"key":"R33-15-20210305","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00005176-200010000-00024","article-title":"Is Lactobacillus GG helpful in children with Crohns disease Results of a preliminary open-label study.","volume":"31","author":"Gupta","year":"2000","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R34-15-20210305","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1572-0241.2006.00734.x","article-title":"Efficacy of an encapsulated probiotic Bifidobacterium Infantis 35624 in women with irritable bowel syndrome.","volume":"101","author":"Whorwell","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R35-15-20210305","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2004.11.050","article-title":"Lactobacillus and Bifidobacterium in irritable bowel syndrome (IB): symptom responses and relationship to cytokine profiles.","volume":"128","author":"OMahony","year":"2005","journal-title":"Gastroenterology"},{"key":"R36-15-20210305","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1046\/j.1365-2036.2003.01543.x","article-title":"A randomized controlled trial of a probiotic, VSL3 on gut transit and symptoms in diarrhea-predominant IBS.","volume":"17","author":"Kim","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R37-15-20210305","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2982.2005.00695.x","article-title":"A randomized controlled trial of probiotic combination VSL3 and placebo in IBS with bloating.","volume":"17","author":"Kim","year":"2005","journal-title":"Neurogastroenterol Motil"},{"key":"R38-15-20210305","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2036.2007.03362.x","article-title":"Effect of a fermented milk containing Bifidobacterium animalis DN-172 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized double-blind, controlled trial.","volume":"26","author":"Guyonnet","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R39-15-20210305","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/00042737-200110000-00004","article-title":"A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299 V in patients with irritable bowel syndrome.","volume":"13","author":"Niedzielin","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R40-15-20210305","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0264-410X(95)93319-5","article-title":"Improved immunogenicity of oral DxRRV reassortant rotavirus vaccine by Lactobacillus casei GG.","volume":"13","author":"Isolauri","year":"1995","journal-title":"Vaccine"},{"key":"R41-15-20210305","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1097\/MCG.0b013e3181639a98","article-title":"Probiotics: use in allergic disorders.","volume":"42","author":"Isolauri","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"R42-15-20210305","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1111\/j.1572-0241.2002.05946.x","article-title":"Prevention of radiation-induced diarrhea with the use of VLS3, a new high-potency probiotic preparation.","volume":"97","author":"Delia","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R43-15-20210305","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0009-9260(88)80296-4","article-title":"Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures.","volume":"39","author":"Salminen","year":"1988","journal-title":"Clin Radiol"},{"key":"R44-15-20210305","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-116-5-353","article-title":"Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis.","volume":"116","author":"Hilton","year":"1992","journal-title":"Am Intern Med"},{"key":"R45-15-20210305","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.micinf.2006.08.008","article-title":"Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial.","volume":"8","author":"Anukam","year":"2006","journal-title":"Microbes Infect"},{"key":"R46-15-20210305","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.micinf.2006.08.008","article-title":"Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.","volume":"8","author":"Anukam","year":"2006","journal-title":"Microbes Infect"},{"key":"R47-15-20210305","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1542\/peds.2007-3007","article-title":"Oral probiotics prevent necrotizing enterocolitis in very low birth rate preterm infants: a multicenter, randomized, controlled trial.","volume":"122","author":"Lin","year":"2008","journal-title":"Pediatrics"},{"key":"R48-15-20210305","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/MPG.0b013e3181ca4d95","article-title":"VSL3 improves symptoms in children with irritable bowel syndrome: an international, randomized, placebo-controlled, double-blinded, cross-over study.","volume":"51","author":"Guandalini","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCG.0b013e318230928b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:31:38Z","timestamp":1786048298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004836-201111001-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":46,"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e318230928b","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}